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A spontaneous mitonuclear epistasis converging
on Rieske Fe-S protein exacerbates complex III
deﬁciency in mice
Janne Purhonen1,2, Vladislav Grigorjev1, Robert Ekiert 3, Noora Aho4,5, Jayasimman Rajendran 1,2,
Rafał Pietras 3, Katarina Truvé 6, Mårten Wikström 7, Vivek Sharma4,7, Artur Osyczka3,
Vineta Fellman 1,2,8,9,10 & Jukka Kallijärvi 1,2,10*
We previously observed an unexpected ﬁvefold (35 vs. 200 days) difference in the survival of
respiratory chain complex III (CIII) deﬁcient Bcs1lp.S78G mice between two congenic back-
grounds. Here, we identify a spontaneous homoplasmic mtDNA variant (m.G14904A, mt-
Cybp.D254N), affecting the CIII subunit cytochrome b (MT-CYB), in the background with short
survival. We utilize maternal inheritance of mtDNA to conﬁrm this as the causative variant
and show that it further decreases the low CIII activity in Bcs1lp.S78G tissues to below survival
threshold by 35 days of age. Molecular dynamics simulations predict D254N to restrict the
ﬂexibility of MT-CYB ef loop, potentially affecting RISP dynamics. In Rhodobacter cytochrome
bc1 complex the equivalent substitution causes a kinetics defect with longer occupancy of
RISP head domain towards the quinol oxidation site. These ﬁndings represent a unique case
of spontaneous mitonuclear epistasis and highlight the role of mtDNA variation as modiﬁer of
mitochondrial disease phenotypes.
https://doi.org/10.1038/s41467-019-14201-2 OPEN
1 Folkhälsan Institute of Genetics, Folkhälsan Research Center, P.O. Box 63 (Haartmaninkatu 8), FI-00014 Helsinki, Finland. 2 Stem Cells and Metabolism
Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 3 Department of Molecular Biophysics, Faculty of Biochemistry, Biophysics,
and Biotechnology, Jagiellonian University, ul. Gronostajowa 7, 30-387 Kraków, Poland. 4Department of Physics, University of Helsinki, P.O. Box 64 (Gustaf
Hällströmin katu 2), FI-00014 Helsinki, Finland. 5 Department of Chemistry, University of Jyväskylä, P.O. Box 35 (Survontie 9B), FI-40014 Jyväskylä, Finland.
6 Sahlgrenska Academy, University of Gothenburg, P.O. Box 413 (Medicinaregatan 3), 41390 Gothenburg, Sweden. 7 Institute of Biotechnology, University of
Helsinki, PL 56 (Viikinkaari 9), FI-00014 Helsinki, Finland. 8 Department of Clinical Sciences, Pediatrics, BMC F12, Lund University, 221 84 Lund, Sweden.
9 Children’s Hospital, Helsinki University Hospital, P.O. Box 281 (Stenbäckinkatu 11), FI-00029 Helsinki, Finland. 10These authors contributed equally: Vineta
Fellman, Jukka Kallijärvi. *email: jukka.kallijarvi@helsinki.ﬁ
NATURE COMMUNICATIONS |          (2020) 11:322 | https://doi.org/10.1038/s41467-019-14201-2 |www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
M itochondrial respiratory chain complex III (cyto-chrome bc1 complex, CIII) oxidizes coenzyme Q,reduces cytochrome c, and translocates protons to
generate membrane potential for ATP synthesis1. The mito-
chondrial inner membrane AAA-family translocase BCS1L,
frequently mutated in CIII deﬁciency2–4, is required for the
topogenesis of the electron-transferring RISP (Rieske iron-sulphur
protein, UQCRFS1) subunit and its assembly into CIII5–7.
Homozygous Bcs1lc.A232G (Bcs1lp.S78G) knock-in mice8, carrying a
GRACILE syndrome9,10 patient mutation3, recapitulate many
manifestations of human CIII deﬁciency. They display post-
weaning growth failure, hepatopathy, renal tubulopathy, and, in a
C57BL/6JBomTac-derived genetic background (Lund colony),
deterioration due to metabolic crisis with extreme hypoglycemia
by 35 days of age (P35)11–13. When we brought the mutant strain
to another facility via embryo transfer and bred it with the closely
related C57BL/6JCrl background (Helsinki colony), the homo-
zygotes developed similar early visceral and systemic manifesta-
tions but, unexpectedly, survived the early metabolic crisis
and lived ﬁvefold longer, to up to 200 days14,15. Suspecting genetic
drift in the isolated Lund colony, we hypothesized that (a)
homozygous genetic change(s) underlie the highly consistent
survival difference between the two colonies. Here we perform
whole-genome sequencing (WGS) to identify candidate
variants, followed by a simple genetic experiment to show that a
spontaneous mitochondrial DNA (mtDNA) variant underlies
the survival difference. We combine mouse phenotyping,
computational, and spectroscopic data to show how the effects of
this non-pathogenic variant and the disease-causing Bcs1l muta-
tion converge to exacerbate CIII deﬁciency and disease
progression.
Results
Short-lived Bcs1lp.S78G mice carry a novel mtDNA variant.
WGS (n= 3 for Lund C57BL/6JBomTac and n= 2 for Helsinki
C57BL/6JCrl) revealed 844 homozygous single-nucleotide poly-
morphisms and 3655 small insertion/deletions between the
strains, only 8 of which were in coding regions of genes (Sup-
plementary Table 1). One of these was an mtDNA variant (m.
G14904A) not present in any Mus musculus sequence in Gen-
Bank. Genotyping of approximately 80 mice throughout past
generations using archived genomic DNA from ear biopsies
revealed that the variant was introduced from wild-type (WT)
C57BL/6JBomTac females repeatedly after 2008, when con-
genization of the Bcs1lc.A232G knock-in allele was started (Sup-
plementary Fig. 1a). Inspection of the pedigrees of the mt-Cyb-
genotyped mice showed that two early-generation females had
given birth to both WT and variant-carrying progeny, suggesting
initial heteroplasmy. However, sequencing of 346 bacterial clones
of mt-Cyb PCR amplicon from the liver, kidney, heart, and
skeletal muscle DNA showed no sign of heteroplasmy in somatic
tissues in later generations (Supplementary Fig. 1b). The fact that
the variant was homoplasmic in an apparently healthy WT
mouse colony suggested that it must be non-pathogenic. Indeed,
analysis of mtDNA sequences deposited to GenBank showed that
the three-toed sloth species (Bradypus) of South America, known
for their very low metabolic rate16,17 naturally carry this variant
(Fig. 1a). Intriguingly, the variant affects the mtDNA-encoded
CIII subunit cytochrome b, changing a conserved aspartate 254
to asparagine (mt-Cybp.D254N). A negatively charged amino acid
in this position is highly conserved across eukaryotes and aerobic
prokaryotes (Fig. 1a), with limited conservancy in archaea.
Therefore, as mt-Cybp.D254N potentially directly affects CIII
function, it appeared as a most likely genetic modiﬁer of the
survival of Bcs1lp.S78G mice.
mt-Cybp.D254N dictates the short survival of Bcs1lp.S78G mice.
We utilized maternal inheritance of mtDNA and crossbred
Bcs1lp.S78G heterozygotes from the two inbred colonies to obtain
F1 progeny carrying otherwise equalized nDNA background
(heterozygous for all initially homozygous alleles differing
between the colonies) and either WT or variant mitochondria
(Fig. 1b). The homozygous Bcs1lp.S78G progeny of females from
the Lund colony (C57BL/6JBomTac) had median survival of
38 days while that of females from the Helsinki colony (C57BL/
6JCrl) 150 days (Fig. 1c). As WGS showed no other mtDNA
differences between the strains, the crossbreeding unequivocally
conﬁrmed that the maternally inherited mt-Cybp.D254N variant
was the major determinant of the survival of Bcs1lp.S78G mice.
We have previously described the early-onset disease manifes-
tations (growth restriction, hypoglycemic, hepatopathy, and
kidney tubulopathy) of Bcs1lp.S78G mice in both the short- and
long-living strains separately8,13–15,18,19. Here we reassessed some
of the main manifestations in the genetically comparable F1 mice.
The presence of mt-Cybp.D254N aggravated the growth restriction
of the mutant mice (Fig. 1d). Remarkably, mt-Cybp.D254N alone
also slightly decreased the weight of the F1 juvenile Bcs1l WT
progeny. All Bcs1lp.S78G mice had abnormally low blood glucose,
but in those carrying mt-Cybp.D254N the blood glucose was below
quantiﬁcation limit in several individuals, indicating severe
hypoglycemia expected to lead to coma and death (Fig. 1e).
Histopathological analysis revealed hepatopathy with glycogen
depletion and incipient ﬁbrosis that was similar in both mutant
genotypes up to age P29–P33 (Supplementary Fig. 2). However,
in the very end-stage (>P34) livers, diffuse hepatocyte death was
present, indicating rapid deterioration to fulminant hepatic
failure in the mt-Cybp.D254N-carrying mutants (Supplementary
Fig. 3). Staining for cleaved caspase 3, a standard marker of
apoptosis, conﬁrmed massive hepatic cell death in the end-stage
mt-Cybp.D254N-carrying mutants (Fig. 1g, h, Supplementary
Fig. 3). This time point coincided with near-complete exhaustion
of hepatic ATP (Fig. 1f). In contrast, only few dying hepatocytes
were present in comparable liver sections from Bcs1lp.S78G mice
with WT mitochondria (Fig. 1g, h). Instead of rapid ATP
depletion, these mice showed a trend toward normalization after
P34 (Fig. 1f). These ﬁndings are in line with our previous
studies14,15 showing that the hepatopathy of Bcs1lp.S7Fig.8G mice
in the long-living colony does not progress to liver failure even at
end stage (P150–P200).
The kidneys of all Bcs1lp.S78G mice were atrophic but luminal
casts suggesting proteinuria were obvious only when these mice
carried mt-Cybp.D254N, indicating more advanced kidney disease
(Supplementary Fig. 4).
mt-Cybp.D254N exacerbates CIII deﬁciency in Bcs1lp.S78G mice.
After the crossbreeding experiment showed unequivocally that
mt-Cybp.D254N was the major determinant of the survival of
Bcs1lp.S78G mice, we set out to investigate its effect on CIII
activity. We have previously shown8 that, in the short-living
background, the progressive CIII dysfunction is severest in the
liver, the activity being normal at birth but thereafter rapidly
decreasing to as low as 10% of WT activity near end stage
(P33–P35). The ﬁrst symptoms appear soon (P24) after weaning
at approximately 50% residual activity. Below 25% residual
activity, the mice become severely hypoglycemic and die within a
few days8,13. We measured CIII activity in the key affected (liver,
kidney) and histologically non-affected (skeletal muscle, heart)
tissues in the F1 mice and found that the low CIII activity was
further decreased by mt-Cybp.D254N in all four tissues (Fig. 2). The
mean hepatic CIII activity at P33 was 9% of WT values in mt-
Cybp.D254N;Bcs1lp.S78G mice, well below the survival threshold
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Fig. 1 Identiﬁcation of a spontaneous mtDNA variant as a modiﬁer of Bcs1l mutant phenotype. a Alignment of amino acids 236–275 (numbering forMus
musculus sequence) of MT-CYB protein of various organisms. Asterisk (*), Lund in-house C57BL/6JBomTac-derived mouse colony. b Cartoon of the
crosses to assess the effect of the maternally inherited mtDNA on the survival of Bcs1lp.S78G mice. c Survival analysis of Bcs1lp.S78G mice with either the
C57BL/6JBomTac* (n= 8) or C57BL/6JCrl (Helsinki colony) maternal parent (n= 6). Light blue- and red-shaded areas illustrate 95% CI. d Weight and
e blood glucose of juvenile F1 males. Three mt-Cybp.D254N-carrying Bcs1lp.S78G mice had blood glucose below the limit of quantiﬁcation (LOQ, 1 mmol/l) of
the glucose meter. f Hepatic ATP concentration of Bcs1l mutant mice with and without the mt-Cytbp.D254N variant plotted against mouse age. g The degree
of hepatic apoptosis, cleaved caspase-3-positive cross-sectional area, plotted against age. h Representative micrographs of immunostained liver sections
for cleaved caspase 3 from 34- to 35-day-old mice. Scale bar represents 100 µm. Statistics: c log-rank (Mantel–Cox) test, d one-way ANOVA followed by
planned comparisons, e Kruskal–Wallis followed by Mann–Whitney U tests. Error bars represent 95% CI of the mean in all ﬁgures.
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(Fig. 2a). The mean hepatic CIII activity remained at 25% of WT
in Bcs1lp.S78G homozygotes with WT mt-Cyb (Fig. 2a, c), as also
shown in our earlier studies. Furthermore, the mean CIII activity
of Bcs1lp.S78G homozygotes with WT mtDNA did not decrease
<50% in the kidney and heart, whereas in mt-Cybp.D254N carriers
it did (Fig. 2c, f). Further measurements from a panel of mice
backcrossed several times to the C57BL/6JCrl background con-
ﬁrmed the synergistic effect of Bcs1lp.S78G and mt-Cybp.D254N on
CIII activity (Fig. 2c, d, g, h and Supplementary Fig. 5). Interest-
ingly, mt-Cybp.D254N alone consistently decreased cardiac CIII
activity in both sample panels (Fig. 2f, g, Supplementary Fig 5),
whereas this trend was not as obvious in other tissues (Fig. 2). For
comparison, we analyzed the enzymatic activities of other
respiratory chain complexes in isolated liver and kidney mito-
chondria from the F1 mice (Supplementary Fig. 6). CI and CIV
activities were similar in all groups. CII activity was slightly lower
in the Bcs1lp.S78G;mt-Cybp.D254N liver as compared to the other
genotypes, while in the kidney, CII activity was increased by sole
mt-Cybp.D254N or Bcs1lp.S78G but not by their combination. In sum,
mt-Cybp.D254N further compromised CIII activity in Bcs1lp.S78G
mice, decreasing it below survival threshold.
Aspartate 254 is located in the MT-CYB ef loop involved in
RISP binding20,21, which raised the question whether its
substitution to asparagine might exacerbate the RISP assembly
defect caused by the Bcs1l mutation. To quantify RISP assembled
into CIII, we subjected digitonin-solubilized liver (Fig. 3a) and
kidney (Fig. 3b) mitochondrial fractions to blue native gel
electrophoresis. The steady-state level of RISP in CIII dimer and
supercomplexes was markedly affected by the Bcs1l genotype,
but with no consistent further impairment by mt-Cybp.D254N in
these tissues.
mt-Cybp.D254N modiﬁes mitochondrial bioenergetics. We have
previously shown that CI&CII-linked oxidative phosphorylation
(OXHPOS) is compromised in Bcs1lp.S78G mice in both the short-
and long-living colonies8,15,18. To assess howmt-Cybp.D254N might
affect respiratory electron transfer and OXPHOS, we subjected
liver and kidney mitochondria from the F1 hybrid mice (Sup-
plementary Fig. 7) and a panel of mice backcrossed to C57BL/
6JCrl (Fig. 4, Supplementary Figs. 8 and 9) to high-resolution
respirometry. The CIII defect of Bcs1l mutant mice with or
without mt-Cybp.D254N did not compromise OXPHOS driven by
sole NADH-producing substrates (CI-linked respiration) (Sup-
plementary Figs. 7 and 8) as we have previously reported8,15,18
and in line with known high threshold for CIII inhibition22.
Therefore, we proceeded to assess maximal OXPHOS capacity via
convergent electron ﬂow to the coenzyme Q pool via CI and CII
by subsequent addition of succinate (CI&CII-linked OXPHOS).
This parameter strongly correlated with residual CIII activity
(Supplementary Fig. 10) and revealed the CIII dysfunction in mice
carrying Bcs1lp.S78G and a further exacerbation by mt-Cybp.D254N
(Fig. 4a and Supplementary Figs. 7 and 9).
After measuring CI&CII-linked phosphorylating respiration, we
inhibited ATP synthase with oligomycin to induce leak respiration,
a high membrane potential state in which limited respiration
occurs due to proton leakage. Similar to CI&CII-linked phosphor-
ylating respiration, the CI&CII-linked leak respiration was also low
in Bcs1lp.S78G and even lower in Bcs1lp.S78G;mt-Cybp.D254N tissues
(Fig. 4b and Supplementary Fig. 7). Interestingly, mt-Cybp.D254N
alone decreased CI&CII-linked leak respiration in kidney mito-
chondria (Fig. 4b and Supplementary Fig. 7b). We did not observe
this in liver mitochondria from the F1 hybrids (Supplementary
Fig. 7a), but in liver mitochondria from mice backcrossed to
C57BL/6JCrl (Fig. 4b) the trend was signiﬁcant and similar to that
in the kidney.
In some tissues, the phosphorylating system (adenine nucleo-
tide translocase, phosphate transporters, and the ATP synthase)
limits the electron-transferring proton translocases and subse-
quent respiration. Therefore, we also measured maximal capacity
of the electron transfer by dissipating the membrane potential
a b
g
c d
e f
0
25
50
75
100
125
150
0
25
50
75
100
125
150
Liver
(F1)
%
 o
f W
T 
CI
II 
ac
tiv
ity
p = 0.025
p = 0.033 p = 0.02
p = 0.062
p = 0.003
p = 0.008
p = 0.027 p = 0.031
p = 0.006
p = 0.003
p = 0.019
Liver
(backcrossed)
Skeletal muscle
(F1)
p = 0.001
Heart
(F1)
Heart
(backcrossed)
0
25
50
75
100
125
150
0
25
50
75
100
125
150
Kidney
(F1)
MT-CYB
BCS1L
WT
WT S78G
D254ND254N WT MT-CYB
BCS1L
WT
WT S78G
D254ND254N WT
MT-CYB
BCS1L
WT
WT S78G
D254ND254N WT MT-CYB
BCS1L
WT
WT S78G
D254ND254N WT
MT-CYB
BCS1L
WT
WT S78G
D254ND254N WT
MT-CYB
BCS1L
WT
WT S78G
D254ND254N WT MT-CYB
BCS1L
WT
WT S78G
D254ND254N WT
Kidney
(backcrossed)
%
 o
f W
T 
CI
II 
ac
tiv
ity
0
25
50
75
100
125
150
0
25
50
75
100
125
150
%
 o
f W
T 
CI
II 
ac
tiv
ity
0
25
50
75
100
125
150
0
25
50
75
100
125
150
%
 o
f W
T 
CI
II 
ac
tiv
ity
Skeletal muscle
(backcrossed)
MT-CYB
BCS1L
WT
WT S78G
D254ND254N WT
h
Fig. 2 Synergistic effect of Bcs1lp.S78G and mt-Cybp.D254N on CIII activity.
a–h CIII activity in liver (a, b) and kidney mitochondrial fractions (c, d) and
heart (e, f) and skeletal muscle homogenates (g) from F1 hybrid progeny
(a, c, e, g) and from mice backcrossed to C57BL/6JCrl (b, d, f, h). CIII
activity data from isolated liver and kidney mitochondria were normalized
to mitochondrial protein amount. The data from muscle and heart
homogenates were normalized to relative respiratory chain content as
assessed by measuring cyanide-sensitive cytochrome c oxidation. Cardiac
and skeletal muscle homogenate CIII activity relative to tissue protein are
shown in Supplementary Fig. 5. The orange line represents 50% residual
activity, a threshold for appearance of hypoglycemic and hepatic
manifestations in Bcs1l mutant mice. The red line represents 25% residual
activity, a value observed in the liver of Bcs1l mutant mice in the colony with
short survival at the onset of the terminal stage. Statistics: one-way
ANOVA followed by planned comparisons. Error bars represent 95% CI of
the mean.
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with the protonophore carbonyl cyanide 4-(triﬂuoromethoxy)
phenylhydrazone (FCCP). The rate of uncoupled CI&CII-linked
respiration revealed that the respiration in Bcs1l mutant
mitochondria with or without mt-Cybp.D254N was limited by
both the CIII defect and by the phosphorylating system (Fig. 4c
and Supplementary Fig. 7). mt-Cybp.D254N alone did not limit
CI&CII-linked maximal electron transfer capacity. However, as
the leak respiration was decreased, the mt-Cybp.D254N mice
showed elevated electron transfer coupling efﬁciency (Fig. 4d, e,
Supplementary Fig 7), which is a ratio calculated from leak
respiration and maximal electron transfer capacity. The decreased
leak respiration and increased electron transfer coupling
efﬁciency suggest that mt-Cybp.D254N decreases proton leakage
at CIII, or indirectly elsewhere, or it affects a rate-limiting step in
CIII enzymatic cycle when it is working against high membrane
potential.
Finally, as a measure of CII and CIII-derived reactive oxygen
species production, we measured H2O2 emission under succinate-
driven phosphorylating respiration with reverse electron ﬂow to
CI blocked by rotenone (Supplementary Fig. 11). Total H2O2
emission (per mitochondrial protein) was not signiﬁcantly
different between the groups. However, relative to oxygen
consumption it was increased in the Bcs1lp.S78G mitochondria
from the liver (median: 1.5% vs 0.8%, Mann–Whitney U test
<0.0001) and kidney (0.8% vs 0.5%, p= 0.003) as compared to
Bcs1l WTs.
mt-Cybp.D254N restricts RISP head domain movement. As mt-
Cybp.D254N did not seem to have a consistent effect on CIII
assembly, which is compromised by the Bcs1l mutation, a more
subtle mechanism must underlie their synergistic effect on CIII
activity in mice. We inspected published crystal structures of
eukaryotic CIII to model structural changes that the D254N
amino acid change might cause in MT-CYB or in the complex.
These showed that the RISP head domain (RISP-HD) brushes the
ef loop segment of MT-CYB and docks to both the MT-CYB and
CYTC1 subunits in two different conformations to promote
electron transfer (Fig. 5a–c). Thus an amino acid substitution in
the ef loop segment may lead to compromised RISP dynamics23,24.
In order to obtain further microscopic insight, we performed fully
atomistic classical molecular dynamics (MD) simulations of
cytochrome bc1 in membrane-solvent environment. These showed
that D254N likely restricts the conformational ﬂexibility in the
surrounding region (Fig. 5d–g), displayed as the root mean square
ﬂuctuation of the segment T250 to V270 in the ef loop of MT-
CYB (Fig. 5d), which strongly interacts with RISP. Accordingly,
we observed a simultaneous reduction in mobility for the segment
P136-W146 of RISP (Fig. 5e). A neutral asparagine in this position
interacted with fewer water molecules in comparison to a charged
aspartate (Fig. 5f) and displayed a lower side chain mobility
(Fig. 5g). These data suggested that compromised mobility of the
ef loop and the RISP-HD might affect a rate-limiting step in the
catalytic cycle of CIII in Bcs1lp.S78G mutants in which the CIII
assembly defect may lead to heterodimers25 containing only one
RISP molecule per CIII dimer. When simulations were performed
by modeling a ubiquinol (QH2) and ubiquinone (Q) at the Qo and
Qi sites, respectively, we found that the ﬂexibility of the domains
around D254 locus was reduced in comparison to simulations
without Q molecules (Supplementary Fig. 12). This is in part due
to the brushing of ef loop residues with the QH2 head group. In
WT simulations, residues P270 and Y298 contacted the QH2 head
group (≤3.5 Å criteria) for ca. 70% and 90% of the simulation
time, respectively. Similarly, in mutant simulations, P270 and
Y298 interacted with QH2, for 100 and 18% of total simulation
time, with an additional interaction observed between QH2 and
E271 (48%). These interactions are likely to reduce the ef loop
dynamics in tight coupling with substrate binding and dynamics.
Nevertheless, a subtle difference in mobility was observed for the
ef loop segment in agreement with the current experimental and
earlier biochemical data26.
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To test the predictions of the in silico simulations, we
employed the purple photosynthetic bacterium Rhodobacter
capsulatus, in which the cytochrome b gene can be mutagenized
and the simple three-component bc1 complex puriﬁed and
subjected to sensitive structural and functional measurements.
To this end, we introduced the equivalent mutation, D278N, into
Rhodobacter cytochrome b. As expected from the non-pathogenic
nature of the variant in mice, the subunit composition, spectral
properties, activity, and superoxide production of the mutant
complex were not affected, and it sustained normal bc1-
dependent photosynthetic growth (Supplementary Fig. 13, Sup-
plementary Table 2). To measure RISP movement, predicted by
the MD simulations to be affected by the stiffened mutant ef loop,
we monitored spectroscopically the enhancement of phase
relaxation of RISP [2Fe-2S] cluster by oxidized heme bL27. This
method allows monitoring of changes in the distribution of RISP-
HD positions between the Qo position and cytochrome c1
position. The enhancement is strongest when the motion of RISP-
HD is restricted predominantly toward positions at the Qo site,
such as in the +2Ala mutant (Fig. 5h, i) that was used as one
reference point. Unrestricted motion in the native enzyme
resulted in a much broader distribution of RISP-HD positions
and a relatively weak enhancement (Fig. 5h, i), providing us with
another reference point. The D278N mutant displayed an
increased enhancement compared to native enzyme but not as
large as in the +2Ala. This indicates that the D278N mutation
caused a subtle but remarkable effect on the motion, shifting the
average position of RISP-HD toward the Qo position and
conﬁrming the predictions from the MD simulations of the
eukaryotic complex.
mt-Cybp.D254N modiﬁes whole-body metabolism. To assess the
metabolic effect of mt-Cybp.D254N at whole-body level, we
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Fig. 4 Effect of mt-Cytbp.D254N on oxidative phosphorylation in Bcs1lp.S78G and wild-type mice. a Phosphorylating respiration of liver and kidney
mitochondria upon convergent electron ﬂow to coenzyme Q pool via CI and CII in presence of ADP (CI&CII-linked OXPHOS). Mitochondrial NADH was
generated with a substrate cocktail comprising malate, pyruvate, and glutamate. Succinate served as direct substrate for CII. b Proton leak upon high
membrane potential state was assessed after inhibition of ATP synthase by oligomycin. c Subsequently, a protonophore, FCCP, was titrated to assess the
maximal uncoupled electron transfer (ET) capacity. Maximal oxygen consumption capacity, as measured using ascorbate and TMPD as substrates for the
terminal oxidase (CIV), was set as the reference state for the oxygen ﬂuxes (a–c). Supplementary Fig. 9 shows the same data relative to mitochondrial
protein. d, e ET coupling efﬁciency (1−L/E) as calculated from oligomycin-induced leak respiration (L) and uncoupler-induced maximal CI&CII-linked
electron transfer capacity (E). Samples collected at P30 from backcrossed mice were used for the analyses. Supplementary Fig. 7 shows similar analysis
from F1 hybrid mice. Statistics: One-way ANOVA followed by planned comparisons. Error bars represent 95% CI of the mean.
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subjected the mice to indirect calorimetry (Fig. 6). Bcs1lp.S78G
homozygotes with WT mitochondria did not signiﬁcantly differ
from WT mice during daytime measurements, whereas Bcs1lp.S78G
homozygotes carrying mt-Cybp.D254N variant clearly did, as indi-
cated by low respiratory exchange ratio (RER) and energy
expenditure (Fig. 6a–c). Both parameters suggested a profound
starvation-like metabolic state in these mice. The decreased energy
expenditure remained highly signiﬁcant also after treating body
weight as a covariate. Mice are nocturnal animals and nighttime
whole-body metabolism data showed an even more distinct
separation of Bcs1lp.S78G;mt-Cybp.D254N mice from all other gen-
otypes (Fig. 6a–c). Measurements during nighttime distinguished
also Bcs1lp.S78G mice with WT mitochondria and, surprisingly,
those carrying mt-Cybp.D254N alone from WT mice. In fact,
mt-Cybp.D254N variant and the Bcs1lp.S78G mutation caused a
similar decrease in RER and energy expenditure. Differences in
physical activity did not explain these differences (Supplementary
Fig. 14).
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To shed further light on the metabolic effects of mt-Cybp.D254N,
we measured hepatic gene expression of Fgf21, a mainly hepatocyte-
derived endocrine factor linked to mitochondrial stress and stressed
energy metabolism28, and Gdf15, another circulating marker of
mitochondrial dysfunction29. We have previously shown that both
are induced in Bcs1l mutant mice at later age14,15. Also here Fgf21
and Gdf15 expression were upregulated by the Bcs1l mutation
(Fig. 6d, e), in line with expected metabolic stress and energy
deprivation. Strikingly, mt-Cybp.D254N alone induced the expression
of Fgf21 to similar level as the pathogenic Bcs1l mutation (Fig. 6d),
showing together with the respirometric and indirect calorimetric
data thatmt-Cybp.D254N causes distinct metabolic alterations despite
being an apparently non-pathogenic variant.
Discussion
We discovered an extreme genetic background effect in the sur-
vival of CIII deﬁcient mice and tracked the cause to a sponta-
neous variant in the mtDNA-encoded CIII subunit MT-CYB.
This overtly silent mtDNA variant likely arose >10 years ago
in an isolated colony of C57BL/6JBomTac mice and became
homoplasmic by random drift in the germline, and ﬁnally
expanded to the whole colony from a single common matrilinear
ancestor. Incidentally, Bcs1l mutant mice with defective assembly
of RISP subunit into CIII were generated and congenized in this
facility8. This resulted in transfer of the mtDNA variant-carrying
mitochondria into the Bcs1lp.S78G mice and a hidden genetic
interaction, exacerbating their CIII deﬁciency and causing a lethal
metabolic crisis by 5–6 weeks of age. We discovered this only
after transferring the mice to another facility and crossing them to
a commercial C57BL/6JCrl strain, in which the homozygotes
lived 4–5 times longer. We identiﬁed a candidate mtDNA variant,
mt-Cybp.D254N, using WGS and utilized maternal inheritance of
mtDNA to explicitly show that this variant was the main deter-
minant of the survival.
In addition to BCS1L mutations, also MT-CYB mutations are a
rare cause of CIII deﬁciency in humans. For example, mutations
affecting the ef loop and Qo site cause CIII deﬁciency manifesting as
cardiomyopathy and exercise intolerance30. A heteroplasmic in-
frame deletion of 8 amino acids spanning D254, the amino acid
affected in our mice, was reported in a patient with exercise intol-
erance, a relatively benign phenotype31. Aspartate 254 is located in
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Statistics: one-way ANOVA (b, d, e) or ANCOVA (c) followed by planned comparisons with Welch’s t statistics.
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the RISP binding ef loop of MT-CYB, and patient and artiﬁcial
experimental mutations in this region are known to affect either
quinol oxidation and subsequent electron transfer or RISP
assembly23,24. In our mice,mt-Cybp.D254N did not consistently affect
the steady-state level of RISP in CIII. Instead, MD simulations
predicted that a neutral asparagine in this position stiffens the ef
loop and restricts RISP-HD motion between the Qo and cyto-
chrome c1 sites. Pulse electron paramagnetic resonance (EPR)
measurements in isolated Rhodobacter bc1 complex conﬁrmed this.
In another bacterial system, Rhodobacter sphaeroides, the equivalent
experimental substitution also caused a subtle kinetics defect24. We
propose that, in the Bcs1lp.S78G mice with insufﬁcient RISP assem-
bly, likely leading to heterodimers with only one active Qo site, the
subtle RISP kinetics defect due to D254N becomes limiting,
synergistically decreasing CIII activity. Subsequently, CIII activity
drops below the survival threshold, causing lethal metabolic crisis by
5 weeks of age, while Bcs1lp.S78G mice with WT mtDNA never
become as hypoglycemic, escape the early metabolic crisis, and
survive to up to 6 months. Intriguingly, we found that mt-Cybp.
D254N seemed to subtly modify respiratory chain function and
metabolism of the mice also in the absence of the Bcs1l mutation.
For example, mt-Cybp.D254N alone was sufﬁcient to increase fatty
acid oxidation (low RER) and induce hepatic Fgf21 expression.
The mtDNA sequence data in GenBank show the presence of mt-
Cybp.D254N in three-toed sloths (Bradypus), which feed on an
extremely energy-poor diet16. It is tempting to speculate that the
variant might even be beneﬁcial under some circumstances. Such
circumstances might be linked to a need to maximize energy pre-
servation, as alluded by the fact that mt-Cybp.D254N-carrying mice
had increased electron transfer coupling efﬁciency, decreased leak
respiration, and decreasead nocturnal energy expenditure. Inter-
estingly, in humans the D254N variant (m.G15506A) appears in
mtDNA sequence database as an extremely rare (3 out of 42,616
full-length mtDNA sequences) polymorphism and is predicted to
associate with the African L2b and ancient Central Asian U4b
haplogroups (www.mitomap.org).
Lack of methodology to introduce speciﬁc mutations into the
multicopy mtDNA is still a major limitation in the study of
mitochondrial disorders and physiology32,33. Other naturally
occurring mtDNA variants, carried mostly by outbred mouse
strains and of unknown effect on their own, have been bred into
various nuclear genetic backgrounds to generate so called con-
plastic mice. Such strains can be utilized in studies of crosstalk
between the mitochondrial and nuclear genomes in the context of
metabolism and aging34,35. Breeding the mt-Cybp.D254N variant
into other nDNA backgrounds could offer a novel tool for these
studies. Studies in the invertebrate model organisms Cae-
norhabditis elegans and Drosophila melanogaster have shown that
subtle suppression of mitochondrial respiration can extend life
span36,37. These ﬁndings have remained largely uncorroborated
in mammalian models because few viable genetic mouse models
with subtle respiratory chain impairment exist38,39. Thus the mt-
Cybp.D254N mice could open up a possibility to test some of the
previous seminal ﬁndings made in the invertebrate models. In
sum, our ﬁndings urge further investigations of the metabolic
effects of this unique spontaneous, homoplasmic mtDNA variant.
Finally, our serendipitous discovery underscores the effect of the
genetic background in mouse disease models and encourages
replication of phenotyping in a different background to
strengthen the biological signiﬁcance of the ﬁndings.
Methods
WGS and Sanger sequencing. Genomic DNA was extracted from frozen liver
tissue using standard sodium dodecyl sulfate (SDS)–proteinase K digestion fol-
lowed by phenol/chloroform extraction and ethanol precipitation. Whole genomes
of mice from a C57BL/6JBomTac-derived colony (n= 3) and of the C57BL/
6JCrl background (n= 2) were sequenced on Illumina HiSeqX platform (National
Genomics Infrastructure, SciLifeLab, Sweden) with 30× coverage. Analysis of the
sequence data was performed using FastQC, TrimGalore, BWA40, GATK41,
Bcftools42, and Annovar ensGene43 software at Bioinformatics Infrastructure for
Life Sciences, Sweden. Mice were genotyped for the mt-Cyb variant by Sanger
sequencing of a PCR fragment (primers: forward 5’-ACCTCCTCTTCCTCCAC-
GAA-3’ and reverse 5’-AGCGTAGAATGGCGTATG
CA-3’). Heteroplasmy was evaluated by cloning the mt-Cyb amplicon from dif-
ferent tissues into pBluescript plasmid and sequencing bacterial clones.
Animal experiments and ethics. Bcs1lc.A232G knock-in mice in congenic C57BL/
6JCrl (Harlan stock 000664) or C57BL/6JBomTac-derived background were
maintained in the animal facilities of University of Helsinki, Finland with 12-h
light/dark cycle at 22–23 °C. Manual behavioral scoring was used to evaluate the
health of homozygous mice as described previously19 and when the score reached
7/12 the animals were considered to be at end stage of the disease and were
euthanized to minimize spontaneous deaths. Genomic DNA was isolated from ear
clippings and the mice were genotyped for the Bcs1lc.A232G mutation as described8.
The animal experiments were authorized by the national Animal Experiment
Board, Finland (ELLA) under the ethical permits ESAVI/6142/04.10.07/2014 and
ESAVI/6365/04.10.07/2017 and carried out in accordance with the Federation of
Laboratory Animal Science Associations (FELASA) guidelines.
Sample collection. The experimental F1 cohort and the mice backcrossed at least
thrice to C57BL/6JCrl were fasted for 2 h during the light cycle of the animals
before sample collection. The mice were euthanized by carbon dioxide inhalation
followed by cervical dislocation. Blood glucose was measured using Freestyle Lite
(Abbott, UK) meter. Tissues were immediately collected for histology, mitochon-
drial isolation, and/or snap-frozen in liquid nitrogen for storage at −80 °C.
Tissue histology and immunohistochemistry. Formalin-ﬁxed parafﬁn-embedded
tissues were processed and 5-µm sections stained according to routine procedures
for general histology (hematoxylin–eosin (H&E)), glycogen (periodic acid-Schiff
(PAS)), and collagen (Sirius Red). For cleaved caspase 3 staining (rabbit mono-
clonal antibody (mAb) 5A1E, cat. no. #9664, Cell Signaling Technology Inc.),
antigen retrieval was performed by boiling the deparafﬁnized sections for 20 min in
10 mM sodium citrate buffer, pH 6.0. Antibody was diluted 1:1000 and the staining
was performed using Vectastain ABC alkaline phosphatase reagents (Vector
Laboratories Inc.) and nitroblue teterazolium substrate as per the manufacturer’s
protocols. Nuclei were counterstained with Nuclear Fast Red (Sigma).
Quantitative PCR (qPCR). Total RNA was extracted from snap-frozen liver
samples using RNAzol RT reagent (Sigma-Aldrich). RNA purity and concentration
were assessed by reading absorbances at 230, 260, and 280 nm and quality by
inspecting ribosomal bands after agarose-gel electrophoresis. cDNA was synthe-
sized with RevertAid H− reverse transcriptase (Thermo Scientiﬁc, #EP0451) and
random hexamers. qPCR reactions comprised Phire Hot-Start II DNA polymerase
(Thermo Scientiﬁc); EvaGreen DNA-binding dye (Biotum); and buffer, dNTPs,
and primers as instructed by the manufacturer of the polymerase. The following
primer pairs were used: Fgf21 (forward, 5’-AGATGGAGCTCTCTATGGATCG-3’
and reverse 5’-GGGCTTCAGACTGGTACACAT-3’), Gdf15 (forward, 5’-GTCTC
CCCGAAGCCTACC-3’ and reverse 5’-TTCAGGGGCCTAGTGATGTC-3’), Gak
(forward, 5’-CTGCCCACCAGGCATTTG-3’ and reverse 5’-CCATGTCACATAC
ATATTCAATGTACCT-3’), and Rab11a (forward, 5’-AAGGCACAGATATGG
GACACA-3’ and reverse 5’-CCTACTGCTCCACGATAGTATGC-3’). Gak and
Rab11a served as reference genes. CFX96 instrument and CFX Manager software
(Bio-Rad) were utilized to perform the qPCR and data analysis.
Isolation of mitochondria. Liver and kidney samples were rapidly excised, rinsed
of excess blood, minced with scissors, and homogenized in cold isolation buffer
(225 mM mannitol, 75 mM sucrose, 10 mM Tris-HCl, 1 mM EGTA, 0.1% bovine
serum albumin, pH 7.4 at +4 °C) with glass-teﬂon Potter-Elvehjem homogenizers.
Two-step differential centrifugation (800 × g supernatant and 7800 × g pellet, 5 min
each) was used to obtain a crude mitochondrial preparation for respirometry and
Amplex Red-peroxidase assay from the F1 cohort. For other analyses, the isolation
was continued by a puriﬁcation on 19% Percoll (11,300 × g, 10 min) followed by
washing of the pellet (7800 × g, 5 min) with isolation buffer without albumin.
Percoll-puriﬁed fractions were also used for respirometry from the panel of mice
backcrossed to C57BL/6JCrl.
Homogenization of tissues for enzyme activity measurements. Snap-frozen
heart and skeletal muscle (quadriceps) biopsies were prehomogenized for 15 s with
T8 Ultra-Turrax disperser (IKA®-Werke GmbH & Co. KG, Germany) and
thereafter homogenized using PBI-Shredder (Pressure Biosciences Inc., MA, USA).
Mitochondria isolation buffer served as a homogenization media for the skeletal
muscle and 25 mM potassium phosphate buffer (with 40 mM KCl, 1 mM EGTA,
pH 7.5) for the heart. We repeated the measurements from the heart and skeletal
muscle using samples homogenized with roughened glass-to-glass tissue grinders
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(Fig. 2h and Supplementary Fig. 5). Supernatants after low-speed centrifugation
(600 × g 10 min at +4 °C) were used for the enzyme activity measurements.
Assessment of respiratory chain enzymatic activities. CIII activity was assessed
spectrophotometrically by monitoring antimycin A-sensitive cytochrome c
reduction with decylubiquinol as electron donor in the following reaction mixture:
50 mM potassium phosphate pH 7.5, 60 µM cytochrome c, 100 µM decylubiquinol,
2 mM sodium azide, 100 µM EDTA, 0.05% Tween-20 and 0.1 mg/ml bovine serum
albumin (BSA). Decylubiquinone was reduced with NaBH4 and extracted with
2:1 solution of diethylether and isooctane, vacuum dried under nitrogen, and
dissolved in acidiﬁed EtOH (1mM HCl). CIII activity data from isolated mito-
chondria was normalized against mitochondrial protein amount and the data from
homogenates to tissue protein or relative mitochondrial mass as assessed by
measuring CIV activity. Rotenone-sensitive CI activity was measured with NADH
as substrate and decylubiquinone as intermediate electron acceptor coupled to
reduction of a colorimetric dye 2,6-dichloroindophenol (DCIP)44. Succinate oxi-
dation by CII was coupled to reduction of decylubiquinone and ﬁnally DCIP, the
absorbance of which was read at 600 nm45. CIV activity was measured polaro-
graphically with TMPD (N,N,N’,N’-tetramethyl-p-phenylenediamine dihy-
drochloride) and ascorbate as electron donors (liver and kidney) or by monitoring
cyanide-sensitive cytochrome c oxidation spectrophotometrically (quadriceps and
heart). The polarographic assay was corrected for oxygen and sample-dependent
TMPD auto-oxidation by measuring residual oxygen consumption at different
oxygen levels after addition of sodium azide. All assays were performed at 37 °C.
Respirometry. Mitochondrial oxygen consumption was measured in Oxygraph-2k
(OROBOROS Instruments, Innsbruck, Austria) chamber at 37 °C in Mir05 buffer
(110 mM sucrose, 60 mM lactobionic acid, 20 mM taurine, 20 mM HEPES, 10 mM
KH2PO4, 3 mM MgCl2, 0.5 mM EGTA, and 1 g/l fatty acid-free BSA, pH 7.1).
Sample, substrates, inhibitors, and uncoupler were injected in the following order:
(1) 1 mM malate, 5 mM pyruvate, and 5 mM glutamate; (2) sample; (3) 1.25 mM
ADP; (4) 10 µM cytochrome c; (5) 10 mM succinate; (6) 0.5 µg/ml oligomycin A;
(7) FCCP titration to maximum respiration; (8) 0.25 µM rotenone; (9) 1 µg/ml
antimycin A. Different oligomycin preparations and concentrations (0.5 µg/ml, sc-
201551, Santa Cruz vs 0.4 µg/ml, Sigma, O4876) were used for the F1 and later
respirometric panels, respectively. The change in oligomycin preparation, a pro-
blem discussed by Ruas et al.46, may explain why we did not observe decreased leak
respiration in the liver of mt-Cybp.D242N mice in the F1 data. To normalize any
difference in mitochondria mass, we set the maximal capacity of the terminal
oxidase, CIV, as the reference state (polarographic CIV activity assay). This in-
assay normalization has proven to provide a robust normalization as the mea-
surement is performed immediately after the actual respirometry experiment using
same equipment and exactly identical sample amount47. Supplementary Fig. 9
shows CI&CII-linked phosphorylating respiration relative to mitochondrial
protein.
Measurement of mitochondrial H2O2 production. Amplex Ultra Red peroxidase
assay was used to measure mitochondrial H2O2 production simultaneously with
respirometry. Oxygraph-2k was equipped with a ﬂuorometer and appropriate ﬁl-
ters for resoruﬁn ﬂuorescence (OROBOROS Instruments). The assay reagent
concentrations were: 15 µM Amplex Ultra Red (Invitrogen), 1 U/ml horseradish
peroxidase, 5 U/ml superoxide dismutase, 10 mM succinate, 1.25 mM ADP, and
0.25 µM rotenone. Horseradish peroxidase-independent Amplex Red oxidation by
mitochondrial carboxylesterases48 was inhibited by 50 µM phenylmethylsulfonyl
ﬂuoride. Grossly similar O2 concentrations were maintained for all samples. The
assay was calibrated with a 0.2-nmol bolus of H2O2. Stock concentration of H2O2
was determined by reading 240 nm absorbance and by employing extinction
coefﬁcient of 43.6 M/cm. The background was obtained after addition of catalase
(0.5 kU/ml).
Blue native gel electrophoresis. Frozen pelleted mitochondria were solubilized
using 6mg digitonin per mg protein in cold solubilization buffer (750mM amino-
caproic acid, 50mM Bis-Tris, 14mg/ml digitonin, 1 mM EDTA, pH 7.0 at +4 °C).
The solubilized fraction was cleared by centrifugation (18,000 × g, +4 °C, 15 min)
and glycerol (5%) and Coomassie Blue G-250 (1.5 mg/ml) were added to the
supernatant. Fifteen µg (liver) or 8 µg (kidney) of solubilized mitochondrial protein
were resolved in 3–12% NativePAGETM Bis-Tris gradient gels (Invitrogen)
according to the manufacturer’s protocol. Following the electrophoresis, the pro-
teins were denatured in 1% SDS for 10 min followed by gel equilibration for 15 min
in transfer buffer. Semi-dry electroblotting (25 V, 45 min with ~7 mm interelec-
trode distance) onto 0.2 µm polyvinylidene diﬂuoride (PVDF) ﬁlter was performed
using modiﬁed Bjerrum Schafer-Nielsen Buffer (48 mM Tris, 39 mM glycine) with
cathode buffer supplemented to contain 10% MeOH and 0.05% SDS and anode
buffer containing 20% MeOH. After the transfer, background staining was
removed using 10% AcOH, 50% MeOH and the transferred proteins were imaged.
Complete destaining was accomplished with 100% MeOH before proceeding to
immunostaining using the following mAbs from MitoSciences/Abcam: RISP
(clone, 5A5), CORE2 (13G12AF12BB11), NDUFA9 (20C11B11B11), ATP5A
(15H4C4), and SDHB (21A11AE7). These antibodies were used at concentrations
ranging from 0.2 to 0.3 µg/ml with incubation times ranging from 16 to 20 h at
~8 °C. The primary antibodies were detected using peroxidase-conjugated antibody
against mouse IgG (Dako, cat. no. P0047), chemiluminescence, and digital imager
(ChemiDoc MP, Bio-Rad). Samples subjected for quantiﬁcation were loaded onto
two 15-well gels in a randomized order. These two gels were simultaneously blotted
onto single PVDF membrane, which was thereafter processed as a single unit. The
dynamic range of quantiﬁcation was assessed with a dilution series.
Indirect calorimetry. In vivo oxygen consumption and carbon dioxide production
were measured using Comprehensive Lab Animal Monitoring System (CLAMS)
(Columbus Instruments). The mice were acclimatized in the cages for a minimum
of 6 h before the collection of experimental data. This system also recoded
movement of the mice.
Computational methods. For the crystal structure analyses, structures 1BE347,
1L0L20, 1L0N27, 1SQV49, and 2FYU50 were used. For the MD simulations, a model
system of WT enzyme was constructed using the high-resolution (1.9 Å) crystal
structure of cytochrome bc1 from Saccharomyces cerevisiae (PDB: 3CX5)51.
Detergent molecules, cyt c, Qo site inhibitor stigmatellin, and other crystallographic
lipid molecules were removed prior to the modeling set-up. Since cytochrome bc1
functions as a homodimer, we incorporated the entire protein structure into a lipid
bilayer using CHARMM-GUI52,53. The lipid bilayer consisted of three different
types of lipids representing the composition of inner mitochondrial membrane,
that is, 50.3% POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) 35.0%
POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine), and 14.7% car-
diolipin. The membrane–protein set-up was solvated with water molecules and K+
and Cl− ions to neutralize the system charge as well as to mimic the 150 mM salt
concentration. A similar modeling set-up was applied to construct the mutant
(D254N) system (D255 in S. cerevisiae). The atomic partial charges of metal
cofactors as well as bonded and non-bonded parameters were taken from an earlier
study54. All redox centers were modeled in their oxidized state. We also performed
atomistic MD simulations in the presence of ubiquinone (Q) and ubiquinol (QH2),
for which a QH2 molecule at the Qo site and an oxidized Q molecule at the Qi site,
were modeled by aligning to the positions of stigmatellin (PDB: 3CX5) and qui-
none (Q6 in PDB: 1EZV55), respectively. The force ﬁeld parameters of Q molecules
were taken from an earlier study56. For all components of the system, CHARMM
force ﬁeld was used57,58, and simulations were performed with the GROMACS
program59. The entire system was energy minimized (ca. 6000 steps) using Steepest
Descent method available in GROMACS, followed by an equilibration (60 ns). The
long production runs (1 μs each for WT and mutant systems, totaling 4 μs) were
performed at constant temperature (310 K) and pressure (1 atm), which were
established with the use of Nose–Hoover thermostat60,61 and Parrinello–Rahman
barostat62, respectively. Long-ranged electrostatics was dealt with PME63 imple-
mented in GROMACS, and LINCS algorithm64 was used to achieve 2 fs time step.
Alignment of trajectories was performed using the protein backbone atoms on to
the zeroth frame. The data were plotted as an average from both monomers and
also separately (Supplementary Figs. 15 and 16).
Studies in bacteria. A mutant strain of R. capsulatus containing the substitution of
aspartic acid to asparagine on position 278 in cytochrome b and a Strep tag at its C-
terminus was generated with QuikChange site-directed mutagenesis method
(Stratagene) using the pPET1 plasmid (containing WT petABC operon) as a
template and following PCR primers for mutagenesis (the changed nucleotide in
the underlined triplet is in bold):
D278N_F: 5’-CTCGGCCACCCGAACAACTACGTCCAGG-3’ and
D278N-R: 5’-CTGGACGTAGTTGTTCGGGTGGCCGAGG-3’.
The BstXI/AsuII restriction fragment bearing the introduced mutation was
exchanged with its counterpart on a PMTS1-WT plasmid vector and introduced
into the MT-RBC1 R. capsulatus strain devoid of petABC operon using triparental
crossing method65. The presence of the introduced mutation was conﬁrmed by
sequencing the inserted fragment on a plasmid isolated from R. capsulatus D278N
strain.
R. capsulatus strains expressing WT or D278N cytochrome bc1 complex were
cultured semi-aerobically in MPYE medium. Chromatophores were isolated from
pellets of 5-liter bacterial cultures in 50 mM MOPS buffer pH 7.0, 100 mM KCl,
and 1 mM EDTA using French press. For cytochrome bc1 complex puriﬁcation,
chromatophores were solubilized with n-dodecyl-β-D-maltopyranoside detergent
(Anatrace) in 50 mM Tris buffer pH 8.0, 100 mM NaCl, and 1 mM EDTA,
ultracentrifuged, and the supernatant was applied on Strep-tag afﬁnity
chromatography columns (IBA)66. X-band CW EPR spectra of the [2Fe-2S] cluster
were measured on Bruker Elexsys E580 spectrometer using Bruker SHQ4122
resonator equipped with an ESR900 cryostat (Oxford Instruments). Measurement
parameters were as follows: microwave frequency 9.38 GHz, microwave power 2
mW, modulation amplitude 1.5 mT, modulation frequency 100 kHz, and
temperature 20 K.
Pulse EPR measurements of [2Fe-2S] cluster relaxation. The temperature
dependence of phase relaxation rates of the reduced [2Fe–2 S] cluster was mea-
sured by pulse EPR spectroscopy in a way similar to that established by Sarewicz
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-14201-2
10 NATURE COMMUNICATIONS |          (2020) 11:322 | https://doi.org/10.1038/s41467-019-14201-2 | www.nature.com/naturecommunications
et al.27,67. Measurements were carried out on Bruker Elexsys E580 spectrometer
using Q-band ER5107D2 resonator inserted into CF935 cryostat. Samples of
puriﬁed cytochrome bc1 complexes were prepared in bicine buffer pH 8.0 con-
taining 100 mM NaCl, 20% glycerol, and 1 mM sodium ascorbate. Spin echo decay
traces were recorded with the use of two pulse sequence (π/2–τ–π) in which the
pulse separation time (τ) was swept. Starting from shortest available τ= 160 ns, the
separation time was sequentially incremented by 4 ns interval in 1024 steps. Each
time point of the trace was obtained by integration of the spin echo signal
appearing after 2 τ time. The length of the π/2 and π pulses was set to 16 and 32 ns,
respectively, and the microwave power was adjusted to give maximum spin echo
signal. Each spin echo decay trace was registered at g= 1.9 transition of the [2Fe-
2S] cluster spectrum, which for Q-band frequency of 33.6 GHz corresponds to
1264 mT magnetic ﬁeld induction. Relaxation rates of the reduced [2Fe–2 S] cluster
were obtained by ﬁtting exponential decay to the electron spin echo traces mea-
sured in 12–23 K temperature range.
Statistics. Survival data were analyzed with log-rank (Mantel–Cox) test. One-way
analysis of variance (ANOVA) and four planned comparisons (t statistics with
Welch’s correction when appropriate) were performed for normally distributed
data: (1) WT vs Bcs1lp.S78G, (2) WT vs mt-Cybp.D254N, (3) Bcs1lp.S78G vs Bcs1lp.S78G;
mt-Cybp.D254N, and (4) WT and mt-Cybp.D254N vs Bcs1lp.S78G and Bcs1lp.S78G;mt-
Cybp.D254N. The normality assumption of ANOVA was assessed with
Shapiro–Wilk method and by manually inspecting the distribution of ANOVA
residuals. When required, Kruskal–Wallis and Mann–Whitney U tests were used
instead. Analysis of covariance with genotype as a ﬁxed factor and body weight as a
covariate was used to calculate weight-normalized energy expenditure. All tests
were performed as two-sided tests. The experimental unit (n) in the analyses was
one individual animal. Throughout the ﬁgures, the data are presented as mean and
95% conﬁdence interval of the mean if not otherwise stated. The data points in
scatter plots are biological independent replicates.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data are available as Source Data ﬁle. Starting structures and input parameters for
molecular dynamics simulations are available at https://doi.org/10.5281/zenodo.3383766.
We have deposited the mt-Cyb variant nucleotide sequence to GenBank (accession
MN627229) and WGS data to NCBI Sequence Read Archive (https://www.ncbi.nlm.nih.
gov/bioproject/596083, BioSample accessions SAMN13612044, SAMN13612045,
SAMN13612046, SAMN13612047, SAMN13612048). Detailed protocols are available
from the authors upon request.
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